| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 53,881 | 61,578 | 56,407 | 62,921 | | Cost of Revenue | 19,234 | 21,860 | 22,212 | 21,954 | | | Gross Profit | 34,647 | 39,718 | 34,195 | 40,967 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,183 | 25,700 | 26,121 | 26,603 | | Non Recurring |
-
|
-
| 3,141 |
-
| | Others | 1,514 | 1,800 | 1,748 | 1,968 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,950 | 12,218 | 3,185 | 12,396 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (272) | (498) | 1,269 | (511) | | Earnings Before Interest And Taxes | 7,678 | 11,720 | 4,454 | 11,885 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 7,678 | 11,720 | 4,454 | 11,885 | | Income Tax Expense | 3,378 | 5,568 | 1,823 | 2,731 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,300 | 6,152 | 2,631 | 9,154 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,300 | 6,152 | 2,631 | 9,154 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,300 | $6,152 | $2,631 | $9,154 |
|
0.31% Nasdaq 
0.05%
Income Statement
